BP’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

BP’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-14,144	Closed	-$358K	–	322
2014 Q3	$358K	Buy	+14,144	New	+$373K	0.01%	295

Other funds holding PTLA

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BP's PTLA Position: Q4 2014 in Review

BP sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2014, closing a stake of 14,144 shares — an estimated $358K sold.

BP first reported a position in PTLA in Q3 2014 and held it in 1 quarter. The position peaked at $358K in Q3 2014. 133 funds tracked by Wall St. Rank hold PTLA as of Q4 2014.

BP reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
BP sold 14,144 Portola Pharmaceuticals, Inc. shares in Q4 2014, an estimated $358K.
BP first reported a position in Portola Pharmaceuticals, Inc. in Q3 2014 and held it in 1 quarter.
BP's Portola Pharmaceuticals, Inc. position peaked at $358K in Q3 2014.
133 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2014.

Based on BP's 13F filing for Q4 2014, filed 17 Feb 2015.